Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) [Phase 1]
Phase 1 study of Micro Needle Array-Doxorubicin (MNA-D) for Cutaneous T-cell Lymphoma has completed, evaluating a microneedle-based delivery…
-
FDA approval · 2024-08-07FDA Approved: LYMPHIR — Original Application (Citius Pharmaceuticals, Inc.)
FDA approved LYMPHIR (denileukin diftitox-CXDL) through an original application for the treatment of CD25-expressing cutaneous T-cell lympho…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies [Phase 1]
Tinostamustine, a first-in-class alkylating HDAC inhibitor fusion molecule, completed its Phase 1 study in relapsed/refractory hematologic m…
-
CLINICAL_TRIALS safety_alert · 2024-07-24Clinical Trial Update: Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
A post-authorization safety study is evaluating safety outcomes of allogeneic hematopoietic stem cell transplantation in patients previously…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab [Phase 2]
Phase 2 trial evaluating letermovir for prevention of cytomegalovirus reactivation in patients with hematologic malignancies treated with al…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
This clinical trial update describes a retrospective analysis of a drug-metabolizing genotype in cancer patients and analyzes correlations w…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
This clinical trial is investigating molecular-subtyping-based therapeutic strategies for Cutaneous T-cell Lymphoma and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: VircapSeq Virus Detection in Sézary Syndrome
A completed study evaluated VircapSeq virus detection in patients with Sézary syndrome, a form of cutaneous T-cell lymphoma, with results po…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides [NA]
This trial evaluated biodynamic imaging to predict response to gemcitabine in cutaneous T-cell lymphoma (mycosis fungoides); the study was t…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis
This clinical trial update discusses the investigation of allogeneic hematopoietic stem cell transplantation for epidermotropic cutaneous T-…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Mogamulizumab Q4week Dosing in Participants With R/R CTCL [Phase 2]
Phase 2 trial update describes mogamulizumab dose every 4 weeks in relapsed/refractory cutaneous T-cell lymphoma participants; trial status …
-
FDA approval · 2024-03-06FDA Approved: BEXAROTENE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for bexarotene from Mylan Pharmaceuticals Inc., marking regulatory approval of the supplemental subm…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: L19IL2/L19TNF in Skin Cancer Patients [Phase 2]
Phase 2 clinical trial update for L19IL2/L19TNF in skin cancer patients with various skin cancers; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study [Phase 1, Phase 2]
Phase 1/2 trial exploring linperlisib plus chidamide in relapsed/refractory cutaneous T-cell lymphoma; current status not provided.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: AFM13 in Relapsed/Refractory Cutaneous Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial updates for AFM13 in relapsed/refractory cutaneous T-cell lymphoma have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma [Phase 2]
Phase 2 trial update reporting pharmacokinetics and ECG determinations after 8 weeks of HyBryte treatment in Cutaneous T-Cell Lymphoma/Mycos…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. [Phase 2]
Phase 2 trial update for HuMax-CD4 in cutaneous T-cell lymphoma (skin).
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T-cell lymphoma …
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin. [Phase 2]
Phase 2 clinical trial update for HuMax-CD4 in advanced cutaneous T-cell lymphoma (skin).
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) [Phase 2]
A Phase 2 clinical trial of dimethylfumarate (DMF) in patients with cutaneous T cell lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease [Phase 1, Phase 2]
Clinical trial update on modification of extracorporeal photopheresis for Cutaneous T-cell Lymphoma and chronic graft-versus-host disease in…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms [Phase 2]
Phase 2 study of BGB-A317 (tislelizumab) in adults with relapsed or refractory mature T- and NK-cell neoplasms has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) [Phase 1]
Phase 1 trial evaluating subcutaneous recombinant human IL-15 in combination with alemtuzumab for refractory or relapsed adult T-cell leukem…
-
FDA approval · 2022-04-27FDA Approved: BEXAROTENE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for BEXAROTENE from Amneal Pharmaceuticals NY LLC.